SciELO - Scientific Electronic Library Online

vol.39 issue3-4The Persian Gulf illness is still an enigma for military medicineOverselective embolization of renal angiomyolipoma author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand




  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO


Revista Cubana de Medicina Militar

Print version ISSN 0138-6557On-line version ISSN 1561-3046


CORREA JAUREGUI, Manuel. The inhibitors of the phosphodiesterases in treatment of erectile sexual dysfunction. Rev Cub Med Mil [online]. 2010, vol.39, n.3-4, pp.255-264. ISSN 0138-6557.

The male sexual dysfunction imposes a significantly negative burden in health, in the interpersonal relations, in self-esteem, and the quality of life of those suffering it. Up to at the end of the 80 decade, treatment was limited to psychosexual therapy and to penile implants and the cause was due to mainly to psychological factors. The appearance of oral inhibitors of phosphodiesterase-5 like the Sildenafil citrate (Viagra) in1998, was from its onsets a real revolution and now are the first choice for treatment of erectile dysfunction because it is well tolerated, effective, non-invasive and with a good response rate. In present paper authors made a review of the use of phosphodiesterases inhibitors in treatment of the erectile sexual dysfunction, as well as the relevant features of the drugs nowadays more used contributing to its knowledge and its prescription. The aim of present paper was to look for the more updated papers published in Pubmed and Medline. Phosphodiesterase inhibitors (Sildenafil, Vardenafil and Tadalafil) are the choice drugs in treatment of erectile dysfunction due to its demonstrated effectiveness, safety and tolerance.

Keywords : Erectile sexual dysfunction; phosphodiesterase-5; nitric oxide.

        · abstract in Spanish     · text in Spanish


Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License